Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Notes Payables (2018 - 2025)

Historic Notes Payables for Dr Reddys Laboratories (RDY) over the last 10 years, with Q1 2025 value amounting to $439.3 million.

  • Dr Reddys Laboratories' Notes Payables rose 18677.0% to $439.3 million in Q1 2025 from the same period last year, while for Mar 2025 it was $439.3 million, marking a year-over-year increase of 18677.0%. This contributed to the annual value of $445.0 million for FY2025, which is 19084.97% up from last year.
  • Latest data reveals that Dr Reddys Laboratories reported Notes Payables of $439.3 million as of Q1 2025, which was up 18677.0% from $537273.4 recorded in Q3 2024.
  • Over the past 5 years, Dr Reddys Laboratories' Notes Payables peaked at $439.3 million during Q1 2025, and registered a low of $37628.3 during Q3 2022.
  • For the 5-year period, Dr Reddys Laboratories' Notes Payables averaged around $170.1 million, with its median value being $121.6 million (2023).
  • As far as peak fluctuations go, Dr Reddys Laboratories' Notes Payables crashed by 7503.97% in 2023, and later soared by 101034.56% in 2024.
  • Dr Reddys Laboratories' Notes Payables (Quarter) stood at $317.3 million in 2021, then plummeted by 99.99% to $37628.3 in 2022, then rose by 28.59% to $48387.9 in 2023, then surged by 1010.35% to $537273.4 in 2024, then skyrocketed by 81673.07% to $439.3 million in 2025.
  • Its Notes Payables was $439.3 million in Q1 2025, compared to $537273.4 in Q3 2024 and $153.2 million in Q1 2024.